EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H32O4 |
| Net Charge | 0 |
| Average Mass | 360.494 |
| Monoisotopic Mass | 360.23006 |
| SMILES | CC/C=C\C[C@@H](O)/C=C\C=C\C=C\[C@H](O)C/C=C\C/C=C\CCC(=O)O |
| InChI | InChI=1S/C22H32O4/c1-2-3-10-15-20(23)17-12-8-9-13-18-21(24)16-11-6-4-5-7-14-19-22(25)26/h3,5-13,17-18,20-21,23-24H,2,4,14-16,19H2,1H3,(H,25,26)/b7-5-,9-8+,10-3-,11-6-,17-12-,18-13+/t20-,21-/m1/s1 |
| InChIKey | CRDZYJSQHCXHEG-HBMALMRFSA-N |
| Roles Classification |
|---|
| Chemical Role: | Bronsted acid A molecular entity capable of donating a hydron to an acceptor (Brønsted base). |
| Biological Roles: | human xenobiotic metabolite Any human metabolite produced by metabolism of a xenobiotic compound in humans. specialised pro-resolving mediator A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation. |
| Applications: | anti-inflammatory agent Any compound that has anti-inflammatory effects. specialised pro-resolving mediator A class of cell signaling molecules enzymatically derived from n-3 long chain polyunsaturated fatty acids that have important roles in orchestrating the resolution of tissue inflammation. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| aspirin-triggered protectin D1 (CHEBI:140202) has role anti-inflammatory agent (CHEBI:67079) |
| aspirin-triggered protectin D1 (CHEBI:140202) has role human xenobiotic metabolite (CHEBI:76967) |
| aspirin-triggered protectin D1 (CHEBI:140202) has role neuroprotective agent (CHEBI:63726) |
| aspirin-triggered protectin D1 (CHEBI:140202) has role specialised pro-resolving mediator (CHEBI:140399) |
| aspirin-triggered protectin D1 (CHEBI:140202) is a dihydroxydocosahexaenoic acid (CHEBI:137348) |
| aspirin-triggered protectin D1 (CHEBI:140202) is a secondary allylic alcohol (CHEBI:134396) |
| aspirin-triggered protectin D1 (CHEBI:140202) is conjugate acid of aspirin-triggered protectin D1(1−) (CHEBI:140208) |
| Incoming Relation(s) |
| aspirin-triggered protectin D1(1−) (CHEBI:140208) is conjugate base of aspirin-triggered protectin D1 (CHEBI:140202) |
| IUPAC Name |
|---|
| (4Z,7Z,10R,11E,13E,15Z,17R,19Z)-10,17-dihydroxydocosa-4,7,11,13,15,19-hexaenoic acid |
| Synonyms | Source |
|---|---|
| 10(R),17(R)-dihydroxydocosa-4Z,7Z,11E,13E,15Z,19Z-hexaenoic acid | ChEBI |
| (4Z,7Z,10R,11E,13E,15Z,17R,19Z)-10,17-dihydroxydocosahexaenoic acid | ChEBI |
| aspirin-triggered neuroprotectin D1 | ChEBI |
| AT-NPD1 | ChEBI |
| AT-(NPD1/PD1) | ChEBI |
| AT-PD1 | ChEBI |
| Registry Numbers | Sources |
|---|---|
| Reaxys:22110134 | Reaxys |
| Citations |
|---|